社区孕前护理项目改善孕前糖尿病女性的妊娠准备
该前瞻性队列研究在422家初级保健机构和10家专科产前糖尿病门诊中开展社区孕前护理项目,比较干预前后842次妊娠的妊娠准备指标。结果显示2型糖尿病女性达到目标HbA1c、每日服用5 mg叶酸及「最佳」妊娠准备的比例均提高,1型糖尿病女性首次产前检查时间提前,其他指标无变化。
要点
- 社区孕前护理项目使2型糖尿病女性达到目标HbA1c≤48 mmol/mol(6.5%)的比例从44.4%升至58.5%(p=0.016)。
- 2型糖尿病女性每日服用5 mg叶酸的比例从23.5%升至41.8%(p=0.001),「最佳」妊娠准备从5.8%升至15.1%(p=0.021)。
- 1型糖尿病女性在孕8周前首次产前检查的比例从54.0%升至67.3%(p=0.003),其他指标无变化。
核心结论
- 实用的社区孕前护理项目与2型糖尿病女性妊娠准备的临床相关改善相关。
- 据作者所知,这是首个改善2型糖尿病女性妊娠准备的社区孕前护理干预。
研究设计与样本
- 前瞻性队列研究,比较2013年6月1日至2017年2月28日期间孕前糖尿病女性在孕前护理干预前与干预中/后的妊娠准备指标。
- 研究设置于422家初级保健机构和10家国民健康服务体系专科产前糖尿病门诊。
- 共纳入842次连续妊娠:干预前502次,干预中/后340次。
主要发现
- 306家(73%)初级保健机构积极参与孕前护理项目;初级保健数据库识别出5075名18-45岁糖尿病女性,向4558名(89.8%)合格女性提供了孕前护理宣传册。
- 2型糖尿病女性干预中/后达到目标HbA1c≤48 mmol/mol(6.5%)的比例为58.5%,干预前为44.4%(p=0.016)。
- 2型糖尿病女性干预中/后每日服用5 mg叶酸的比例为41.8%,干预前为23.5%(p=0.001)。
- 2型糖尿病女性干预中/后「最佳」妊娠准备比例为15.1%,干预前为5.8%(p=0.021),改善近三倍。
- 1型糖尿病女性干预中/后在孕8周前首次产前检查的比例为67.3%,干预前为54.0%(p=0.003),其他指标无变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Women with diabetes remain at increased risk of adverse pregnancy outcomes associated with poor pregnancy preparation. However, women with type 2 diabetes are less aware of and less likely to access pre-pregnancy care (PPC) compared with women with type 1 diabetes. We developed and evaluated a community-based PPC programme with the aim of improving pregnancy preparation in all women with pregestational diabetes. METHODS: This was a prospective cohort study comparing pregnancy preparation measures before and during/after the PPC intervention in women with pre-existing diabetes from 1 June 2013 to 28 February 2017. The setting was 422 primary care practices and ten National Health Service specialist antenatal diabetes clinics. A multifaceted approach was taken to engage women with diabetes and community healthcare teams. This included identifying and sending PPC information leaflets to all eligible women, electronic preconception care templates, online education modules and resources, and regional meetings and educational events. Key outcomes were preconception folic acid supplementation, maternal HbA1c level, use of potentially harmful medications at conception and gestational age at first presentation, before and during/after the PPC programme. RESULTS: A total of 306 (73%) primary care practices actively participated in the PPC programme. Primary care databases were used to identify 5075 women with diabetes aged 18-45 years. PPC leaflets were provided to 4558 (89.8%) eligible women. There were 842 consecutive pregnancies in women with diabetes: 502 before and 340 during/after the PPC intervention. During/after the PPC intervention, pregnant women with type 2 diabetes were more likely to achieve target HbA1c levels ≤48 mmol/mol (6.5%) (44.4% of women before vs 58.5% of women during/after PPC intervention; p = 0.016) and to take 5 mg folic acid daily (23.5% and 41.8%; p = 0.001). There was an almost threefold improvement in 'optimal' pregnancy preparation in women with type 2 diabetes (5.8% and 15.1%; p = 0.021). Women with type 1 diabetes presented for earlier antenatal care during/after PPC (54.0% vs 67.3% before 8 weeks' gestation; p = 0.003) with no other changes. CONCLUSIONS/INTERPRETATION: A pragmatic community-based PPC programme was associated with clinically relevant improvements in pregnancy preparation in women with type 2 diabetes. To our knowledge, this is the first community-based PPC intervention to improve pregnancy preparation for women with type 2 diabetes. DATA AVAILABILITY: Further details of the data collection methodology, individual clinic data and the full audit reports for healthcare professionals and service users are available from https://digital.nhs.uk/data-and-information/clinical-audits-and-registries/our-clinical-audits-and-registries/national-pregnancy-in-diabetes-audit .
引用
- Yamamoto JM, Hughes DJF, Evans ML, et al. Community-based pre-pregnancy care programme improves pregnancy preparation in women with pregestational diabetes. Diabetologia. 2018. PMID: 29744539. doi:10.1007/s00125-018-4613-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。